Waksal Harlan

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 34% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Waksal Harlan's trades of Lyra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
283.63
Quantity 24,339 -4.6%
Value US$1,015,503
Transaction date
Purchase
Price
300.36
Quantity 13,852 +44.3%
Value US$29,102
Transaction date
Purchase
Price
2.93
Quantity 16,000 +11.7%
Value US$46,811
Transaction date
Purchase
Price
3.96
Quantity 12,600 +10.1%
Value US$49,859
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-25 2025-04-25
PrS Proposed sale
25,595
224.04
US$1,393,174 		25,595 224.04 US$1,393,174
2023-11-13 2023-11-10
B Purchase
24,339 -4.6%
283.63
US$1,015,503 		24,339 -4.6% 283.63 US$1,015,503
2022-04-13 2022-04-12
B Purchase
13,852 +44.3%
300.36
US$29,102 		13,852 +44.3% 300.36 US$29,102
2020-03-16 2020-03-13
B Purchase
16,000 +11.7%
2.93
US$46,811 		16,000 +11.7% 2.93 US$46,811
2020-03-11 2020-03-11
B Purchase
12,600 +10.1%
3.96
US$49,859 		12,600 +10.1% 3.96 US$49,859